Showing posts with label amyloidosis. Show all posts
Showing posts with label amyloidosis. Show all posts

Saturday, March 7, 2015

FDA authorizes use of first device to treat patients with dialysis-related amyloidosis

FDA: The U.S. Food and Drug Administration today authorized use of Lixelle Beta 2-microglobulin Apheresis Column, the first device to treat dialysis-related amyloidosis (DRA).